Search results for "interleukin"

showing 10 items of 1856 documents

Interleukin 2 treatment in HIV-1 infection

2006

Interleukin 2Text miningbusiness.industryImmunologymedicineHuman immunodeficiency virus (HIV)InterleukinGeneral Medicinebusinessmedicine.disease_causemedicine.drugThe Lancet
researchProduct

2-hydroxy-methyl-1(N-phtaloyltryptophyl) aziridine stimule la prolifération in vitro des lymphocytes humains et la sécrétion des interleukines

2008

Resume But de l’etude Il a ete demontre que les aziridines possedent une activite immunotropique marquee. Dans ce travail, les effets in vitro d’une aziridine nouvellement synthetisee (2-hydroxy-methyl-1(N-phtaloyltryptophyl) aziridine) sont determines sur la proliferation des lymphocytes humains stimules par les agents mitogenes, et sur la secretion des interleukines 2 et 6 (IL-2, IL-6). Materiel et methodes Les lymphocytes du sang peripherique sont isoles par centrifugation differentielle dans un gradient de Ficoll-Paque. Ils sont mis en culture en presence d’agents mitogenes (concanavaline A, lipopolysaccharide) et de differentes concentrations de l’aziridine testee. La determination de …

Interleukin 2biologyChemistrymedicine.medical_treatmentLymphocyteInterleukinGeneral MedicineLymphocyte proliferationMolecular biologyInterleukine 2Cytokinemedicine.anatomical_structuremedicinebiology.proteinInterleukin 6medicine.drugPathologie Biologie
researchProduct

Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-α-treated patients with chronic hepatitis C

2001

This study aimed to characterise the immune mechanisms relevant to viral clearance in interferon (IFN)-alpha-treated chronic hepatitis C virus (HCV) infection. Proliferative responses of peripheral blood mononuclear cells from sustained complete IFN-alpha therapy responders (n = 8), nonresponders (n = 13), untreated patients (n = 10), and healthy controls (n = 5) were measured retrospectively upon stimulation with recombinant HCV-antigens (core, helicase, NS3, NS4, and NS5) and the secretion of IFN-gamma and interleukins (IL-4, IL-5, IL-10, and IL-12) were tested by ELISA. Furthermore, IFN-gamma as well as IL-10 secreting CD4+ T cells were quantitated by intracellular cytokine staining. Ant…

Interleukin 2biologybusiness.industrymedicine.medical_treatmentvirus diseasesVirologyImmunoglobulin GInterleukin 10Infectious DiseasesImmune systemCytokineInterferonVirologyImmunologybiology.proteinMedicineInterferon gammaAntibodybusinessmedicine.drugJournal of Medical Virology
researchProduct

Gene Therapy of Human Melanoma — from Animal Experiments to the Clinical Trial

1997

Low immunogenecity of tumour cells is one of the reason that specific immune response is insufficient to destroy malignant cells. In an attempt to augment weakly immunogenic B78H1 mouse melanoma cell line, these cells were transfected with genomic DNA from a line of human melanoma cells expressing a 96kD melanoma associated antigen (MAA) that is intercellular adhesion molecule 1 (ICAM 1). The transfected cells expressed fivefold higher quantities of the melanoma associated antigen from which the DNA was obtained. Human ICAM 1 expressed by mouse melanoma cells appeared to be highly immunogenic leading to the rejection of the modified mouse melanoma cells. The transfected cells appeared to be…

Interleukin 2business.industryMelanomamedicine.diseaseAcquired immune systemImmune systemImmunophenotypingAntigenmedicineCancer researchCytotoxic T cellIL-2 receptorbusinessmedicine.drug
researchProduct

Monocyte Interleukin-1 Secretion Is Regulated by the Sequential Action of γ-Interferon and Interleukin-2 Involving Monocyte Surface Expression of Int…

1989

Interleukin-1 (IL-1) is a polypeptide synthesized as a high-mol.-wt. precursor and subsequently secreted after proteolytic cleavage to 17500-dalton active forms in murine [1] and human cells [2]. Recently, cDNAs for murine [3] and for two distinct human IL-1 species, IL-1α and IL- 1β, have been isolated, sequenced, and cloned [2, 4].

Interleukin 2medicine.anatomical_structureChemistryMonocytemedicineInterleukinSurface expressionSecretionγ interferonCleavage (embryo)ReceptorMolecular biologymedicine.drug
researchProduct

Expansion of intestinal CD4+CD25highTreg cells in patients with ankylosing spondylitis: A putative role for interleukin-10 in preventing intestinal T…

2010

Objective Subclinical gut inflammation has been demonstrated in patients with ankylosing spondylitis (AS). This study was undertaken to determine the frequency of regulatory CD4+CD25high T cells (Treg cells) and to evaluate Treg cell–related cytokines (interleukin-2 [IL-2], transforming growth factor β [TGFβ], and IL-10) and transcription factors (FoxP3 and STAT-5) in the ileum of patients with AS. Methods Quantitative gene expression analysis, by reverse transcriptase–polymerase chain reaction, of Treg-related cytokines (IL-2, TGFβ, and IL-10) and transcription factors (STAT-5 and FoxP3) was performed on ileal biopsy specimens from 18 patients with AS, 15 patients with active Crohn's disea…

Interleukin 2medicine.diagnostic_testImmunologyFOXP3InflammationBiologyInterleukin 10RheumatologyIntestinal mucosaImmunologyBiopsymedicineInterleukin 23Immunology and AllergyPharmacology (medical)medicine.symptomTransforming growth factormedicine.drugArthritis & Rheumatism
researchProduct

Effect of isoprinosine on IL-2, IFN-γ and IL-4 production in vivo and in vitro

1991

The effects of an immunopotentiating drug, isoprinosine, on the splenocytes of BALB/c mice to produce cytokines were investigated. Isoprinosine enhanced IL-2 production, upregulating the expression of IL-2 receptor in vitro. It also significantly increased the IFN-gamma secretion and decreased the IL-4 production in vivo. The significance of these findings in terms of immune regulation is discussed.

Interleukin 2medicine.drug_classImmunologyIn Vitro TechniquesBiologyImmunostimulantInterferon-gammaMiceT-Lymphocyte SubsetsIn vivoInosine PranobexmedicineSplenocyteAnimalsInterferon gammaReceptorInterleukin 4PharmacologyMice Inbred BALB CIn vitroImmunologyInterleukin-2FemaleInterleukin-3Interleukin-4Spleenmedicine.drugInternational Journal of Immunopharmacology
researchProduct

Induction Therapy with Idarubicin, Ara-C, and VP-16, Followed by G-CSF and Maintenance Immunotherapy with Interleukin-2 for High-Risk AML

1996

Aggressive chemotherapy followed by administration of G-CSF and maintenance therapy with interleukin-2 was evaluated in 16 patients with advanced myelodxysplastic syndrome, 47 patients with AML evolving from myelodysplastic syndromes, 3 patients with subacute myeloid leukemia and 5 patients with secondary AML. Median age was 59 years (range: 23 to 76 years). All patients achieving a complete remission (CR) after two induction courses went on to receive two consolidation courses, to be followed by randomization to either high-dose or low-dose IL-2 to evaluate the potential of IL-2 to eliminate residual leukemic cells and to prolong the duration of CR. Patients ≤ age 55 with an HLA identical …

Interleukin 2medicine.medical_specialtyAcute leukemiaChemotherapyRandomizationbusiness.industrymedicine.medical_treatmentMyelodysplastic syndromesImmunotherapymedicine.diseaseGastroenterologyMaintenance therapyInternal medicinemedicineIdarubicinbusinessmedicine.drug
researchProduct

IL-13 receptor α 2: A regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts

2005

Background IL-13 and IL-4 share many functional properties as a result of their use of a common receptor complex comprising IL-13 receptor α 1 (IL-13Rα1) and IL-4 receptor α (IL-4Rα). The nonsignaling receptor IL-13 receptor α 2 (IL-13Rα2) binds IL-13 with high affinity and specificity and is believed to be a decoy receptor for IL-13. Objective We sought to examine the inhibitory effects of soluble and membrane-bound IL-13Rα2 on IL-13– and IL-4–mediated effects. Methods Primary human fibroblasts were grown from endobronchial biopsy specimens obtained from volunteers. Upregulation of IL-13Rα2 mRNA was measured by means of RT-PCR, and the level of surface expression was measured by means of F…

Interleukin 2medicine.medical_specialtyReceptor complexmedicine.medical_treatmentImmunologyGene ExpressionBronchiBiologyDownregulation and upregulationInternal medicinemedicineHumansImmunology and AllergyRNA MessengerReceptorCells CulturedInterleukin-13Reverse Transcriptase Polymerase Chain ReactionReceptors Interleukin-13FibroblastsFlow CytometryUp-RegulationCell biologyEndocrinologyCytokineInterleukin 13STAT proteinInterleukin-4Signal transductionSignal Transductionmedicine.drugJournal of Allergy and Clinical Immunology
researchProduct

Growth, interleukin-2 production, and responsiveness to IL-2 in T4- positive T Lymphocyte populations from malignant cutaneous T cell lymphoma (Sezar…

1984

Abstract Functional analysis and surface phenotyping using monoclonal antibodies have revealed that malignant T lymphocyte populations in the peripheral blood of patients with Sezary's syndrome resemble the T helper cell populations from normal individuals. In this article we have studied the effects of the immunosuppressive drug cyclosporine A (CsA) on growth, interleukin-2 (IL-2) production, and the induction of IL-2 responsiveness of peripheral blood monocytes (PBMs) from five patients with Sezary's syndrome in vitro, using the lectin phytohemagglutinin (PHA) and the phorbol ester phorbol myristate acetate (PMA) as stimuli. The following results were obtained: PHA-induced cell proliferat…

Interleukin 2medicine.medical_specialtyT cellImmunologyCyclosporinsBiologyLymphocyte ActivationBiochemistryCyclosporin aInternal medicinemedicineHumansSezary SyndromePhytohemagglutininsReceptorCell growthCutaneous T-cell lymphomaT-Lymphocytes Helper-InducerCell BiologyHematologyT helper cellT lymphocytemedicine.diseasePhenotypemedicine.anatomical_structureEndocrinologyInterleukin-2Tetradecanoylphorbol Acetatemedicine.drugBlood
researchProduct